Arcus Biosciences
Price & Volume
Stats
See moreOpen | $9.13 |
Previous Close | $9.12 |
Day Range | $8.31-$9.13 |
52W Range | $8.82-$19.11 |
Market Cap | $965.2M |
Shares Short | 6M |
Financials
See moreRevenue (12 Mos) | $258M |
Revenue Growth (YoY) | -16.1% |
Gross Profit (12 Mos) | -$190M |
Diluted EPS | -$3.14 |
News
See moreYahoo Finance • 5 months ago
Arcus Biosciences Announces New Employment Inducement Grants
Yahoo Finance • 7 months ago
Arcus Biosciences Secures Up to $250 Million Term Loan Facility from Hercules Capital
Yahoo Finance • last year
Exelixis and Arcus Biosciences Announce Clinical Trial Collaboration to Evaluate Zanzalintinib in Combination with AB521 in Patients with Advanced Renal Cell Carcinoma
Yahoo Finance • last year
Arcus Biosciences, Inc. (NYSE:RCUS) Q3 2023 Earnings Call Transcript
About
CEO | Dr. Terry J. Rosen Ph.D. |
CFO | Mr. Robert C. Goeltz II |
Address | 3928 Point Eden Way, Hayward, CA, United States, 94545 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 627 |
